Evidence map›Paper›PMID 37891630›Full record

ArticleHarm reduction journal2023

"As safe as possible": a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids.

David Frank, Luther Elliott, Charles M Cleland, Suzan M Walters, Paul J Joudrey, Danielle M Russell, Beth E Meyerson, Alex S Bennett

Abstract read
In one paragraph

Article in Harm reduction journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Using illicit drugs alone in Vancouver, Canada: a gender-based analysis.Substance abuse treatment, prevention, and policy · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

David FrankDepartment of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY, 10003, USA. dfrank40@gmail.com.
Luther ElliottDepartment of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY, 10003, USA.
Charles M ClelandCenter for Drug Use and HIV/HCV Research, School of Global Public Health, New York University, New York, NY, 10003, USA.
Suzan M WaltersCenter for Drug Use and HIV/HCV Research, School of Global Public Health, New York University, New York, NY, 10003, USA.
Paul J JoudreyDivision of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
Danielle M RussellDepartment of Family and Community Medicine, University of Arizona, Tucson, AZ, 85711, USA.
Beth E MeyersonHarm Reduction Research Lab, Department of Family and Community Medicine, College of Medicine, University of Arizona, Tucson, AZ, 85711, USA.
Alex S BennettDepartment of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY, 10003, USA.

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
Substance Use and HIV Prevention Research in Minority Communities Training ProgramR25DA028567 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Julia Lechuga, Torsten Brian Neilands · 2009 to 2026
$5.4M
Overdose Risk Management and Compensation in the Era of NaloxoneR01DA046653 · NIDA · NEW YORK UNIVERSITY · PI BENNETT, ALEXANDER S, ELLIOTT, LUTHER · 2018 to 2022
$4.4M
Evaluation of a community-based education, navigation, and support (CENS) intervention to reduce opioid-related harms among military veteransR01DA052426 · NIDA · NEW YORK UNIVERSITY · PI BENNETT, ALEXANDER S, ELLIOTT, LUTHER · 2021 to 2025
$3.4M
NIDA NIH HHS 3RO1DA046653-04S1NIDA NIH HHS P30 DA011041NIDA NIH HHS R01 DA046653NIDA NIH HHS R01DA046653NIDA NIH HHS R01 DA052426NIDA NIH HHS R25 DA028567
6 · The paper itself

Abstract

backgroundOpioid withdrawal is a regular occurrence among many people who use illicit opioids (PWUIO) that has also been shown to increase their willingness to engage in risk-involved behavior. The proliferation of fentanyl in the illicit opioid market may have amplified this relationship, potentially putting PWUIO at greater risk of negative health outcomes. Understanding the relationship between withdrawal and risk-involved behavior may also have important implications for the ways that problematic drug use is conceptualized, particularly in disease models of addiction, which position risk behavior as evidence of pathology that helps to justify ontological distinctions between addicts and non-addicts. Examining withdrawal, and its role in PWUIO's willingness to engage in risk, may aid in the development of alternative theories of risk involvement and create discursive spaces for de-medicalizing and de-othering people who use illegal drugs.

methodsThis article is based on 32 semi-structured interviews with PWUIO in the New York City area who also reported recent withdrawal experience. Interviews were conducted remotely between April and August 2022 and recorded for later transcription. Data were then coded and analyzed based on a combination of inductive and deductive coding strategies and informed by the literature.

resultsParticipants described a strong relationship between withdrawal and their willingness to engage in risk-involved behavior that was exacerbated by the proliferation of fentanyl. Yet, their descriptions did not align with narratives of risk as a product of bad decisions made by individuals. Rather, data demonstrated the substantial role of social and structural context, particularly drug policies like prohibition and criminalization, in the kinds of risks that PWUIO faced and their ability to respond to them.

conclusionsWithdrawal should be taken more seriously both from an ethical perspective and as an important catalyst of risk behavior. However, theories that position activities taken to avoid withdrawal as irrational and as evidence of pathology are poorly aligned with the complexity of PWUIO's actual lives. We recommend the use of less deterministic and less medicalized theories of risk that better account for differences between how people view the world, and for the role of socio-structural forces in the production of risk.

Indexed as

Drug OverdoseSubstance-Related DisordersSubstance Withdrawal SyndromeAnalgesics, OpioidFentanylHumansRisk-TakingAnalgesics, OpioidFentanylAddictionDisease modelFentanylHarm reductionMedicalizationOpioid useRiskWithdrawal

Identifiers

PMID37891630
PMCPMC10605476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.